APPLICATION
ANDA040506
TYPE
ANDA
ORIGINAL APPROVAL
2003-12-22
LATEST ACTION
2014-01-10
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Prescription
Products
ETHOSUXIMIDEPrescription
ETHOSUXIMIDE 250MG/5ML · SYRUP · ORAL
Approval history
2014-01-10Labeling · Supplement 4 · standardAP
2009-12-10Labeling · Supplement 3AP
2008-08-15Labeling · Supplement 2AP
2003-12-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.